<DOC>
	<DOCNO>NCT02643355</DOCNO>
	<brief_summary>Withdrawal opioids clinical scenario emergency department physician encounter frequently . Patients present opioid withdrawal display symptom agitation , anxiety , myalgia , abdominal pain , diarrhea , nausea , vomit . Currently , standard treatment opioid withdrawal clonidine ( alpha-2 adrenergic agonist ) , well supportive care ( anti-emetics , intravenous fluid ) . Olanzapine atypical antipsychotic give frequently ED many symptom see patient experience opioid withdrawal , however use toxidrome never study . The hypothesis study olanzapine safe efficacious option compare clonidine treatment opioid withdrawal emergency department .</brief_summary>
	<brief_title>Utility Olanzapine Treatment Opioid Withdrawal ED</brief_title>
	<detailed_description>This study randomize control trial patient randomize receive intramuscular olanzapine oral clonidine first intervention give treatment opiate withdrawal . This study blind . Screening enrollment : Research Associates screen patient review electronic medical record . When patient identify , RA approach CITI train ED provider obtain write informed consent . Allergies either medication screen Epic research associate . Allergies also verify provider complete consent . Study protocol : If patient consent enroll study , research associate randomize patient receive olanzapine clonidine first treatment intervention . The ED provider order medication patient administer nursing staff . At time provider may order patient peripheral IV place IV fluid administer discretion . No supportive measure ( anti-emetics , non-narcotic pain medication ) may give time . Prior medication administration , research associate ass patient 's withdrawal symptom use Clinical Opiate Withdrawal Scale withdrawal symptom . This validated tool use assess degree withdrawal symptom evaluate physiologic symptomatic parameter . The medical provider also obtain information regard patient opioid use history ( type opioid use , chronicity use , date time last use ) . After study medication administration , patient observe clinical improvement . At 30 minute , additional medication intervention may prescribe discretion ED provider symptom control , include crossover study medication . The research associate record medications/interventions order , indication intervention , time administer . Symptoms re-assessed research associate use COWS 60 minute , 120 minute post administration initial treatment intervention , well 4 hour post administration ( approximately time discharge emergency depatment ) . At time mark , sedation patient assess use overt agitation severity scale ( OASS ) . Throughout patient 's ED stay , research associate monitoring adverse complication allergic reaction , dystonia , akathisia , respiratory complication , hypotension . The investigator conduct preliminary data analysis first 25 50 patient enrol , respectively . Initial power analysis sample size calculation delineate investigator would need 35 patient per arm detect 50 % difference need rescue medication 1 hour two study medication .</detailed_description>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Any patient present emergency department provider concern opioid withdrawal contribute symptom presentation eligible inclusion . Age less 18 Allergy either medication ( olanzapine , clonidine ) Inability give informed consent Known pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Narcotic Withdrawal</keyword>
	<keyword>Opiate Withdrawal</keyword>
	<keyword>Emergency Department</keyword>
</DOC>